Lyra Therapeutics (LYRA) Interest & Investment Income (2019 - 2025)
Quarterly Interest & Investment Income fell 61.15% to $169000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 61.62% year-over-year, with the annual reading at $1.1 million for FY2025, 61.62% down from the prior year.
Lyra Therapeutics' Interest & Investment Income history spans 7 years, with the latest figure at $169000.0 for Q4 2025.
- Interest & Investment Income came in at $169000.0 for Q4 2025, down from $256000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.3 million in Q4 2023 to a low of $14000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $354000.0 (2025), against an average of $486350.0.
- Year-over-year, Interest & Investment Income surged 7557.14% in 2023 and then plummeted 72.56% in 2025.
- Lyra Therapeutics' Interest & Investment Income stood at $21000.0 in 2021, then surged by 4342.86% to $933000.0 in 2022, then skyrocketed by 43.41% to $1.3 million in 2023, then crashed by 67.49% to $435000.0 in 2024, then crashed by 61.15% to $169000.0 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Interest & Investment Income are $169000.0 (Q4 2025), $256000.0 (Q3 2025), and $410000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Lyra Therapeutics | - | - | - | 169,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 256,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 298,000.00 |
| Dec 31, 2024 | 435,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 855,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 897,000.00 |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 933,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 34,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 26,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Dec 31, 2020 | 32,000.00 |
| Sep 30, 2020 | 29,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Mar 31, 2020 | 16,000.00 |
| Dec 31, 2019 | 35,000.00 |
| Sep 30, 2019 | 63,000.00 |
| Jun 30, 2019 | 80,000.00 |
| Mar 31, 2019 | 35,000.00 |